Cargando…
Myo-inositol reduces β-catenin activation in colitis
AIM: To assess dietary myo-inositol in reducing stem cell activation in colitis, and validate pβ-catenin(S552) as a biomarker of recurrent dysplasia. METHODS: We examined the effects of dietary myo-inositol treatment on inflammation, pβ-catenin(S552) and pAkt levels by histology and western blot in...
Autores principales: | Bradford, Emily M, Thompson, Corey A, Goretsky, Tatiana, Yang, Guang-Yu, Rodriguez, Luz M, Li, Linheng, Barrett, Terrence A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537179/ https://www.ncbi.nlm.nih.gov/pubmed/28811707 http://dx.doi.org/10.3748/wjg.v23.i28.5115 |
Ejemplares similares
-
2325: Steroid therapy limits stem cell activation required to enact mucosal healing in inflammatory bowel disease
por: Brady Lynch, Evan, et al.
Publicado: (2018) -
Beta-catenin cleavage enhances transcriptional activation
por: Goretsky, Tatiana, et al.
Publicado: (2018) -
SMIT (Sodium-Myo-Inositol Transporter) 1 Regulates Arterial Contractility Through the Modulation of Vascular Kv7 Channels
por: Barrese, Vincenzo, et al.
Publicado: (2020) -
Effects of myo-inositol plus alpha-lactalbumin in myo-inositol-resistant PCOS women
por: Montanino Oliva, Mario, et al.
Publicado: (2018) -
Broad Spectrum Anticancer Activity of Myo-Inositol and Inositol Hexakisphosphate
por: Bizzarri, Mariano, et al.
Publicado: (2016)